Eli Lilly is on a buying spree. Here’s what it means for investors like us

Eli Lilly (LLY) is wisely broadening out its drug pipeline through a series of acquisitions of smaller companies.

from US Top News and Analysis https://ift.tt/nvwepVk
https://ift.tt/bpNWJIF